Literature DB >> 16937033

The treatment of heart failure with preserved ejection fraction ("diastolic heart failure").

Karen Hogg1, John McMurray.   

Abstract

Unlike heart failure with a low ejection fraction, there is no evidence-based treatment for heart failure with preserved ejection fraction which improves clinical outcomes. Indeed, the only evidence for any treatment effect comes from small studies with verapamil where this drug increased exercise capacity and reduced a heart failure score. Large trials are presently underway which are examining the effect of treatment with an ACE inhibitor, ARB and aldosterone antagonist in patients with heart failure and preserved ejection fraction.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16937033     DOI： 10.1007/s10741-006-9488-6

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN： 1382-4147            Impact factor:   4.214


  28 in total

Review 1.  How to treat diastolic heart failure: a personal point of view.

Authors:  W J Remme
Journal:  Rev Port Cardiol       Date:  1999-09       Impact factor: 1.374

2.  Do patients with suspected heart failure and preserved left ventricular systolic function suffer from "diastolic heart failure" or from misdiagnosis? A prospective descriptive study.

Authors:  L Caruana; M C Petrie; A P Davie; J J McMurray
Journal:  BMJ       Date:  2000-07-22

3.  Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance.

Authors:  J F Setaro; B L Zaret; D S Schulman; H R Black; R Soufer
Journal:  Am J Cardiol       Date:  1990-10-15       Impact factor: 2.778

Review 4.  Diagnosis and treatment of diastolic heart failure.

Authors:  H D Weinberger
Journal:  Hosp Pract (1995)       Date:  1999-03-15

Review 5.  The treatment of diastolic heart failure.

Authors:  R J Cody
Journal:  Cardiol Clin       Date:  2000-08       Impact factor: 2.213

Review 6.  Diastolic dysfunction and heart failure: causes and treatment options.

Authors:  M J Garcia
Journal:  Cleve Clin J Med       Date:  2000-10       Impact factor: 2.321

7.  Effect of verapamil in elderly patients with left ventricular diastolic dysfunction as a cause of congestive heart failure.

Authors:  M J Hung; W J Cherng; L T Kuo; C H Wang
Journal:  Int J Clin Pract       Date:  2002 Jan-Feb       Impact factor: 2.503

8.  Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).

Authors:  Marcus D Flather; Marcelo C Shibata; Andrew J S Coats; Dirk J Van Veldhuisen; Aleksandr Parkhomenko; Joszef Borbola; Alain Cohen-Solal; Dan Dumitrascu; Roberto Ferrari; Philippe Lechat; Jordi Soler-Soler; Luigi Tavazzi; Lenka Spinarova; Jiri Toman; Michael Böhm; Stefan D Anker; Simon G Thompson; Philip A Poole-Wilson
Journal:  Eur Heart J       Date:  2005-01-09       Impact factor: 29.983

Review 9.  Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective.

Authors:  R S Vasan; E J Benjamin; D Levy
Journal:  J Am Coll Cardiol       Date:  1995-12       Impact factor: 24.094

10.  Augmentation of diastolic function with phosphodiesterase inhibition in congestive heart failure.

Authors:  P F Binkley; P B Shaffer; J M Ryan; C V Leier
Journal:  J Lab Clin Med       Date:  1989-09
View more
  11 in total

Review 1.  Office management of patients with diastolic heart failure.

Authors:  Katina Tzanetos; Derek Leong; Robert C Wu
Journal:  CMAJ       Date:  2009-03-03       Impact factor: 8.262

Review 2.  Pharmacotherapy of heart failure with normal ejection fraction (HFNEF)--a systematic review.

Authors:  Sujit Rajagopalan; Anjuman Arora; Nusrat Shafiq; Srinivas Reddy S; Promila Pandhi; Niti Mittal; Samir Malhotra
Journal:  Br J Clin Pharmacol       Date:  2011-09       Impact factor: 4.335

3.  Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction.

Authors:  Scott D Solomon; Brian Claggett; Eldrin F Lewis; Akshay Desai; Inder Anand; Nancy K Sweitzer; Eileen O'Meara; Sanjiv J Shah; Sonja McKinlay; Jerome L Fleg; George Sopko; Bertram Pitt; Marc A Pfeffer
Journal:  Eur Heart J       Date:  2015-09-15       Impact factor: 29.983

Review 4.  Heart failure.

Authors:  Robert Samuel McKelvie
Journal:  BMJ Clin Evid       Date:  2010-02-25

5.  Impaired diastolic function in naïve untreated human immunodeficiency virus infected patients.

Authors:  Ugo Oliviero; Giovanni Bonadies; Giorgio Bosso; Maria Foggia; Valentina Apuzzi; Mariarosaria Cotugno; Antonio Valvano; Enrico Leonardi; Guglielmo Borgia; Giuseppe Castello; Raffaele Napoli; Luigi Saccà
Journal:  World J Cardiol       Date:  2010-04-26

Review 6.  Heart failure.

Authors:  Robert Samuel McKelvie
Journal:  BMJ Clin Evid       Date:  2011-08-30

Review 7.  Therapeutic interventions for heart failure with preserved ejection fraction: A summary of current evidence.

Authors:  Muhammad Asrar ul Haq; Chiew Wong; Vivek Mutha; Nagesh Anavekar; Kwang Lim; Peter Barlis; David L Hare
Journal:  World J Cardiol       Date:  2014-02-26

8.  Diastolic dysfunction and heart failure with a preserved ejection fraction: Relevance in critical illness and anaesthesia.

Authors:  R Maharaj
Journal:  J Saudi Heart Assoc       Date:  2012-02-01

Review 9.  Challenging aspects of treatment strategies in heart failure with preserved ejection fraction: "Why did recent clinical trials fail?".

Authors:  Peter Moritz Becher; Nina Fluschnik; Stefan Blankenberg; Dirk Westermann
Journal:  World J Cardiol       Date:  2015-09-26

10.  Comparable performance of the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with preserved and reduced ejection fraction.

Authors:  Susan M Joseph; Eric Novak; Suzanne V Arnold; Philip G Jones; Himad Khattak; Anne E Platts; Victor G Dávila-Román; Douglas L Mann; John A Spertus
Journal:  Circ Heart Fail       Date:  2013-10-15       Impact factor: 8.790
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.